Insider · CIK 0001910456

Lynx1 Capital Management LP

CIK 0001910456 Name as filed on the most recent filing

Filed as Lynx1 Capital Management LP (16)

34 transaction lines · from 16 filings · filed 2023-06-02 to 2026-08-13 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-08-10 P, Open-market purchase Korro Bio, Inc.KRRO 19,279, acquired Open Form 4 filing 0000902664-26-003434
2026-08-06 P, Open-market purchase Korro Bio, Inc.KRRO 59,530, acquired Open Form 4 filing 0000902664-26-003434
2026-06-25 P, Open-market purchase Passage BIO, Inc.PASG 206,101, acquired Open Form 4 filing 0000902664-26-002945
2026-03-31 P, Open-market purchase Korro Bio, Inc.KRRO 5,512, acquired Open Form 4 filing 0000902664-26-001845
2025-12-23 P, Open-market purchase TScan Therapeutics, Inc.TCRX 5,602, acquired Open Form 4 filing 0000902664-25-005396
2025-12-22 P, Open-market purchase TScan Therapeutics, Inc.TCRX 67,950, acquired Open Form 4 filing 0000902664-25-005396
2025-12-19 P, Open-market purchase TScan Therapeutics, Inc.TCRX 71,974, acquired Open Form 4 filing 0000902664-25-005396
2025-10-28 P, Open-market purchase Cullinan Therapeutics, Inc.CGEM 1,391,686, acquired Open Form 4 filing 0000902664-25-004662
2025-10-21 P, Open-market purchase Neuphoria Therapeutics Inc.NEUP 3,283,108, acquired Open Form 4 filing 0000902664-25-004536
2025-10-17 P, Open-market purchase Cullinan Therapeutics, Inc.CGEM 252,565, acquired Open Form 4 filing 0000902664-25-004499
2025-10-16 P, Open-market purchase Cullinan Therapeutics, Inc.CGEM 1,328,250, acquired Open Form 4 filing 0000902664-25-004499
2025-10-15 P, Open-market purchase Cullinan Therapeutics, Inc.CGEM 409,049, acquired Open Form 4 filing 0000902664-25-004499
2025-10-14 P, Open-market purchase Cullinan Therapeutics, Inc.CGEM 114,048, acquired Open Form 4 filing 0000902664-25-004499
2025-10-10 P, Open-market purchase Cullinan Therapeutics, Inc.CGEM 2,041,385, acquired Open Form 4 filing 0000902664-25-004379
2025-10-09 P, Open-market purchase Cullinan Therapeutics, Inc.CGEM 4,191,859, acquired Open Form 4 filing 0000902664-25-004379
2025-10-08 P, Open-market purchase Cullinan Therapeutics, Inc.CGEM 3,593,698, acquired Open Form 4 filing 0000902664-25-004379
2025-09-15 P, Open-market purchase Passage BIO, Inc.PASG 83,175, acquired Open Form 4 filing 0000902664-25-004079
2025-09-12 P, Open-market purchase Passage BIO, Inc.PASG 138,299, acquired Open Form 4 filing 0000902664-25-004079
2025-09-11 P, Open-market purchase Passage BIO, Inc.PASG 2,261, acquired Open Form 4 filing 0000902664-25-004079
2025-07-24 P, Open-market purchase Passage BIO, Inc.PASG 379,455, acquired Open Form 4 filing 0000902664-25-003152
2025-07-23 P, Open-market purchase Passage BIO, Inc.PASG 283,033, acquired Open Form 4 filing 0000902664-25-003152
2025-07-22 P, Open-market purchase Passage BIO, Inc.PASG 71,338, acquired Open Form 4 filing 0000902664-25-003152
2025-05-20 P, Open-market purchase TScan Therapeutics, Inc.TCRX 1,440,000, acquired Open Form 4 filing 0000902664-25-002511
2025-05-19 P, Open-market purchase TScan Therapeutics, Inc.TCRX 1,666,553, acquired Open Form 4 filing 0000902664-25-002511
2024-12-27 P, Open-market purchase Passage BIO, Inc.PASG 241,038, acquired Open Form 4 filing 0000902664-24-007075
2024-12-13 P, Open-market purchase TScan Therapeutics, Inc.TCRX 290,140, acquired Open Form 4 filing 0000902664-24-006934
2024-12-12 P, Open-market purchase TScan Therapeutics, Inc.TCRX 95,629, acquired Open Form 4 filing 0000902664-24-006934
2024-11-27 P, Open-market purchase Passage BIO, Inc.PASG 19,663, acquired Open Form 4 filing 0000902664-24-006799
2024-11-26 P, Open-market purchase Passage BIO, Inc.PASG 118,191, acquired Open Form 4 filing 0000902664-24-006799
2024-11-25 P, Open-market purchase Passage BIO, Inc.PASG 146,665, acquired Open Form 4 filing 0000902664-24-006799
2024-11-15 P, Open-market purchase TScan Therapeutics, Inc.TCRX 4,114, acquired Open Form 4 filing 0000902664-24-006718
2023-05-31 S, Open-market sale TScan Therapeutics, Inc.TCRX 3 lines 63,953, disposed Open Form 4 filing 0000902664-23-003407

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Lynx1 Capital Management LP, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001910456

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.